ABXL
Abacus Global Management, Inc.
$25.56
-0.04%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Jun 10, 2026
SEC
Abacus Global Management published a shareholder letter announcing LifeARC, a proprietary AI-powered lifespan modeling p
8-K — Impact 4/10
Jun 4, 2026
SEC
Shareholders approved the 2026 Long-Term Equity Incentive Plan, authorizing up to 17 million new shares plus evergreen i
8-K — Impact 3/10
May 27, 2026
SEC
Abacus Global Management closed its previously announced $52.9 million minority investment in Manning & Napier, entering
8-K — Impact 4/10
Analyst Ratings
1Strong Buy
7Buy
2Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
4/10
Abacus Global Management published a shareholder letter announcing LifeARC, a proprietary AI-powered lifespan modeling p
Jun 10, 2026
NEUTRAL
8-K
3/10
Shareholders approved the 2026 Long-Term Equity Incentive Plan, authorizing up to 17 million new shares plus evergreen i
Jun 4, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.7/10.
NEUTRAL
8-K
4/10
Abacus Global Management published a shareholder letter announcing LifeARC, a proprietary AI-powered
Jun 10, 2026
NEUTRAL
8-K
3/10
Shareholders approved the 2026 Long-Term Equity Incentive Plan, authorizing up to 17 million new sha
Jun 4, 2026
NEUTRAL
8-K
4/10
Abacus Global Management closed its previously announced $52.9 million minority investment in Mannin
May 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 80% buy across 10 analysts — 1 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 7 | 2 | 0 | 0 | 80% | |
| May 1, 2026 | 1 | 6 | 2 | 0 | 0 | 78% | |
| Apr 1, 2026 | 1 | 6 | 2 | 0 | 0 | 78% | |
| Mar 1, 2026 | 1 | 7 | 1 | 0 | 0 | 89% | |
| Feb 1, 2026 | 1 | 7 | 1 | 0 | 0 | 89% | |
| Jan 1, 2026 | 1 | 7 | 1 | 0 | 0 | 89% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.